Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
12,217 total articles
Jeffrey T. Taylor, Executive Vice President at Velocity Financial, sold 2,130 shares on April 17, 2026, at a weighted average price of $20.00 for proceeds of $42,600. The sale leaves Taylor with 178,985 shares directly held. The transaction occurs as Velocity Financial's stock trades near $19.90 and following a fourth-quarter fiscal 2025 report tha…
Daniel A. Simkowitz, co-president of Morgan Stanley, sold 14,690 shares of the bank's common stock on April 17, 2026, realizing about $2.78 million. The sale occurred as the stock traded close to its 52-week high following a 77.6% year-over-year gain and came after the firm reported stronger-than-expected first-quarter results that prompted several…
International Seaways Senior Vice President and CFO Jeffrey Pribor sold 1,000 shares of company stock on April 15, 2026, under a pre-arranged trading plan. The transaction was executed at $74.50 per share, totaling $74,500. The company recently reported robust fourth-quarter 2025 results, prompting a price-target increase from BTIG and the declarat…
Whitehawk Therapeutics CFO Scott M. Giacobello sold 218,600 shares in two broker-assisted transactions on April 15-16, 2026, raising $882,028 to satisfy tax-withholding on vested restricted stock units. After the sales he holds 295,224 shares. The company recently reported MUC16 expression data at the SGO 2026 meeting and attracted a Market Outperf…
Patrick Lin, Chief Business - Strategy Officer at Processa Pharmaceuticals, purchased 1,369 shares on April 15, 2026, for $2.97 per share, a $4,065 transaction. The stock currently trades at $3.10, up roughly 12% over the past week but still down 59% over six months. An analysis cited in the filing notes a price target of $25, suggesting the compan…
Ryan Cohlhepp, President and COO of Bicara Therapeutics Inc (NASDAQ: BCAX), sold 12,500 shares on April 15, 2026, for $287,591 and concurrently exercised options to acquire 8,000 shares. The transactions occurred under a Rule 10b5-1 plan and come as BCAX trades close to its 52-week high following strong year-over-year gains and recent clinical and …
Processa Pharmaceuticals' Chief Administrative Officer, Wendy Guy, purchased 1,583 shares of the company's common stock on April 15, 2026, at $2.97 per share, a transaction totaling $4,701. After the trade Guy directly holds 4,693 shares and indirectly holds 333 shares through CorLyst, LLC. The stock is trading at $3.10, up 11.91% over the past wee…
International Seaways President and CEO Lois K. Zabrocky sold 2,000 shares of the company's common stock on April 15, 2026, for roughly $149,143 under a Rule 10b5-1 plan. The sale occurred as INSW shares were trading close to a 52-week peak after the company reported strong fourth-quarter 2025 earnings, a record dividend and a bullish response from…
Processa Pharmaceuticals (PCSA) Chief Executive Officer George K. Ng purchased 1,843 shares on April 15, 2026 at $2.97 per share, a transaction totaling about $5,473. The purchase increases Ng's direct holdings to 5,492 shares and follows a recent short-term rise in the stock, which is trading at $3.10 and has gained nearly 12% over the last week. …
Grace Wong-Sarad, Principal Accounting Officer at Alector, Inc. (NASDAQ: ALEC), sold 1,820 shares on April 16, 2026, for $2.65 per share, a transaction valued at $4,823. The sale was made under a Rule 10b5-1 trading plan adopted on September 5, 2025. The stock is trading at $2.57, below InvestingPro's Fair Value estimate, even after a 177% gain ove…
Lauren Freemen-Bosworth, Executive Vice President at Pitney Bowes Inc. (PBI), sold 2,038 shares of company stock on April 16-17, 2026, receiving $25,185 in aggregate. The disposals were part of a pre-arranged Rule 10b5-1 plan adopted October 31, 2025. The sales occurred as the stock trades near its 52-week high and follow quarterly results that bea…
Dennis Polk, a member of TD Synnex's board and chair of Hyve Solutions, sold 2,500 shares of TD Synnex (SNX) on April 17, 2026, for $210.7 per share, totaling $526,750. The disposal was made under a Rule 10b5-1 trading plan adopted by the Polk Family Trust on January 16, 2026. Polk retains direct ownership of 22,439 shares and indirect ownership of…
Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) Co-Global CEO Matthias Aydt purchased one share of the company's Series A Preferred Stock for $100 on April 15, 2026, according to an SEC Form 4. The move is notable for its symbolic value as the electric vehicle maker works to transition from strategic planning to early commercialization whil…
Martine Rothblatt, chairperson and CEO of United Therapeutics Corp (NASDAQ: UTHR), sold $5.48 million of company stock on April 16, 2026, in multiple transactions at prices between $573.9595 and $581.3325. On the same day she exercised options to acquire 9,500 shares at $146.03 per share. The trades were carried out under a 10b5-1 plan adopted Nove…
Steel Connect Sub LLC, a unit of Steel Connect LLC, made three acquisitions of Spruce Power Holding Corp. (NASDAQ: SPRU) shares on April 15-17, 2026 totaling $58,099. The buys bring its direct ownership to 3,405,045 shares. SPRU has returned 98.5% over the past year but is down 19% year-to-date. Recent company disclosures include fourth-quarter rev…
Brian J. Fisher, Executive Vice President of Regional Management Corp (NYSE: RM), sold 2,961 shares on April 17, 2026, under a Rule 10b5-1 plan for $115,330 and exercised options for 8,918 shares. The transactions leave him with 27,745 directly held shares. The company posted Q4 2025 earnings and revenue above analyst forecasts and announced a new …
United Therapeutics Chief Financial Officer and Treasurer Edgemond James sold $5.7 million of company shares on April 16, 2026, and exercised options for 10,000 shares the same day. The trades were made under a Rule 10b5-1 plan as the stock trades near its 52-week high and the company receives regulatory and analyst attention for its pipeline.
CoreWeave Chief Strategy Officer Brian M. Venturo executed a pre-planned sale of 62,447 Class A shares on April 15, 2026, generating roughly $9 million. The transactions occurred under a Rule 10b5-1 plan and coincided with significant corporate developments, including a $6 billion compute capacity agreement with Jane Street and a $1 billion senior …
CoreWeave Chief Operating Officer Sachin Jain executed a sale of 3,953 Class A shares at $120 apiece on April 15, 2026, totaling $474,360. The trade was carried out under a Rule 10b5-1 plan. The transaction coincides with sizable corporate developments including a roughly $6 billion Jane Street agreement, a $1 billion equity investment by Jane Stre…
Mercury Systems' Executive Vice President and CFO, David E. Farnsworth, sold 3,625 shares on April 16, 2026, under a sell-to-cover arrangement to meet tax withholding obligations, generating $307,660. The divestment follows a 77% one-year share price gain and comes amid an InvestingPro assessment that the stock is overvalued relative to its Fair Va…
Trimble Inc. Senior Vice President, AECO, Mark David Schwartz, sold 16,725 shares of common stock on April 16, 2026, for $1.12 million under a Rule 10b5-1 plan established November 7, 2025. The stock has since traded higher at $69.29 but remains below InvestingPro's Fair Value estimate. The company has also announced an acquisition and received sev…
Marcus Corp insider Michael Reade Evans, president of Marcus Hotels & Resorts, executed a sale of 7,671 common shares on April 15, 2026, generating proceeds of $146,087. The transaction, combined with the company's recent fiscal fourth-quarter results and executive changes, provides a snapshot of current insider activity and corporate developments …
Walmart Executive Vice President Daniel J. Bartlett sold 1,335 shares of common stock on April 15, 2026, in a transaction valued at $166,381 that was executed under a Rule 10b5-1 plan and disclosed on a Form 4 filing. After the sale, Bartlett directly holds 636,842.533 shares. The company’s shares trade at $127.50, up 35% over the past year, while …
Walmart Executive Vice President Nicholas Christopher James sold 2,900 shares on April 16, 2026, in two blocks under a Rule 10b5-1 plan, generating $361,695 in proceeds. The company continues to roll out a range of initiatives including a Texas store remodel program, expanded pharmacy weight-management services, a major private-label redesign, a ne…
Michael P. Garthwaite, Vice President and President of Products Pipelines at Kinder Morgan, sold 1,550 shares of the company's Class P common stock on April 16, 2026, under a 10b5-1 plan adopted December 9, 2025. The transaction totaled $49,167 at a weighted average price of $31.721 per share. The company has recent analyst activity and ongoing com…
